Skip to main content

Table 1 Factors influencing malaria parasite prevalence and density in a paediatric HIV infected population in Cameroon

From: Malaria infection and anaemia in HIV-infected children in Mutengene, Southwest Cameroon: a cross sectional study

Characteristic/category Number examined Number positive (%) Bivariate analysis Multivariate analysis GMPD (range) Statistic P-value
OR (95 % CI) P-value$ OR (95 % CI) P-value£
Age Group (years)
  < 5 66 16 (24.2) 1.67 (0.62–4.12) 0.455 1.02 (0.28–3.71) 0.976 633.0 (80–24000) H = 3.406 0.18
 5–10 120 34 (28.3) 1.97 (0.84–4.67) 0.167 3.05 (1.11–8,42) 0.031* 234.0 (40–24000)   
 11–15 48 8 (16.7) Reference     463.3 (40–16000)   
Sex
 Males 96 14 (14.6) Reference     549.0 (40–2400) U = 218.0 0.10
 Females 138 44 (31.9) 2.74 (1.40–5.36) 0.004* 3.08 (1.37–6.93) 0.007* 290.0 (40–24000)   
Fever
 Yes 14 4 (28.6) 1.23 (0.37–4.08) 0.985 1.38 (0.24–7.88) 0.716 3098.4 (400–24000) U = 34.00 0.02*
 No 220 54 (24.5) Reference     287.3 (40–2400)   
CD4 T cell (cells/μl of blood)
  < 200 28 8 (28.6) 1.20 (0.49–2.96) 0.873 1.80 (0.55–5.85) 0.33 82.4 (40–360) H = 11.598 0.003*
 200–499 44 12 (27.3) 1.07 (0.37–3.06) 0.881 1.20 (0.46–3.13) 0.70 405.2 (80–16000)   
  ≥ 500 144 36 (25.0) Reference     491.3 (40–24000)   
Clinical stages
 Stage 1 44 16 (36.4) 4.29 (1.28–14.4) 0,027* 10.38 (2.43–44.46) 0.0016* 191.2 (40–5040) H = 14.36 0.002*
 Stage 2 62 10 (16.1) 1.44 (0.42–5.00) 0.782 1.46 (0.36–5.87) 0.59 512.2 (40–5400)   
 Stage 3 82 24 (29.3) 3.10 (0.99–9.77) 0.077 2.62 (0.76–9.09) 0.13 498.4 (80–2400)   
 Stage 4 34 4 (11.8) Reference     40.0 (40–40)   
Use of ART
 Yes 182 52 (28.6) Reference     314.8 (40–24000) U = 136.00 0.62
 No 52 6 (11.5) 3.07 (1.24–7.61) 0.019* 0.194 (0.06–0.62) 0.0001* 635.0 (40–16000)   
  1. OR Odds Ratio, *Statistically significant, CI Confidence Interval, $:Estimated by Yates adjusted Chi-Square, £:Estimated by Multiple Logistic Regression